Long-term real-world safety and effectiveness of arimoclomol in individuals with NPC: Outcomes from the US early access program over a 4-year period

Study limitation reported by the research below: “Study is published in 2026; regulatory approval status of arimoclomol in the US at time of publication is not stated in the abstract.”